The influence of age on aerosol deposition in children with cystic fibrosis

H.L. Chua, G.G. Collis, A.M. Newbury, K. Chan, C. Bower, P.D. Sly, Peter Lesouef

    Research output: Contribution to journalArticle

    161 Citations (Scopus)

    Abstract

    Nebulized aerosols are commonly used to deliver drugs for the treatment of respiratory disease in children, but there are inadequate data on the dose of drug depositing in the lungs in this age group, and the effect of age on this dose, We therefore aimed to quantify total and regional deposition of nebulized aerosol in children of widely differing age.Twelve infants (median age 0.8 yrs, range 0.3-1.4 yrs) who were asleep, and eight older children (median age 10.8 yrs, range 6.3-18.0 yrs) with cystic fibrosis were studied. Radiolabelled normal saline aerosol was generated by a Turret nebulizer, with a driving flow of 9 l.min(-1). Ah subjects inhaled aerosol via the nasal route, whilst the older children undertook a second study with inhalation via the oral route, Following aerosol inhalation, planar and single-photon emission computed tomography (SPECT) scans were obtained.For the nasal route, total lung deposition was lower in infants (median 1.3%, range 0.3-1.6%) than in older children (median 2.7%, range 1.6-4.4%). For the older children inhaling via the nasal or oral route, there was no influence of age on lung, upper respiratory tract, or the sum of upper respiratory tract and lung deposition.We conclude that the dose of a nasally inspired aerosol reaching the lungs of infants who are asleep is approximately half that for older children, when the nebulizer is operating at 9 l.min(-1). Age does not affect deposition of nasally or orally inspired aerosols in older children.
    Original languageEnglish
    Pages (from-to)2185-2191
    JournalEuropean Respiratory Journal
    Volume7
    DOIs
    Publication statusPublished - 1994

    Fingerprint

    Aerosols
    Cystic Fibrosis
    Lung
    Inhalation
    Nebulizers and Vaporizers
    Nose
    Respiratory System
    Nasal Sprays
    Single-Photon Emission-Computed Tomography
    Pharmaceutical Preparations
    Age Groups

    Cite this

    Chua, H.L. ; Collis, G.G. ; Newbury, A.M. ; Chan, K. ; Bower, C. ; Sly, P.D. ; Lesouef, Peter. / The influence of age on aerosol deposition in children with cystic fibrosis. In: European Respiratory Journal. 1994 ; Vol. 7. pp. 2185-2191.
    @article{72980f2c55984d559f31ed2a9ec0263b,
    title = "The influence of age on aerosol deposition in children with cystic fibrosis",
    abstract = "Nebulized aerosols are commonly used to deliver drugs for the treatment of respiratory disease in children, but there are inadequate data on the dose of drug depositing in the lungs in this age group, and the effect of age on this dose, We therefore aimed to quantify total and regional deposition of nebulized aerosol in children of widely differing age.Twelve infants (median age 0.8 yrs, range 0.3-1.4 yrs) who were asleep, and eight older children (median age 10.8 yrs, range 6.3-18.0 yrs) with cystic fibrosis were studied. Radiolabelled normal saline aerosol was generated by a Turret nebulizer, with a driving flow of 9 l.min(-1). Ah subjects inhaled aerosol via the nasal route, whilst the older children undertook a second study with inhalation via the oral route, Following aerosol inhalation, planar and single-photon emission computed tomography (SPECT) scans were obtained.For the nasal route, total lung deposition was lower in infants (median 1.3{\%}, range 0.3-1.6{\%}) than in older children (median 2.7{\%}, range 1.6-4.4{\%}). For the older children inhaling via the nasal or oral route, there was no influence of age on lung, upper respiratory tract, or the sum of upper respiratory tract and lung deposition.We conclude that the dose of a nasally inspired aerosol reaching the lungs of infants who are asleep is approximately half that for older children, when the nebulizer is operating at 9 l.min(-1). Age does not affect deposition of nasally or orally inspired aerosols in older children.",
    author = "H.L. Chua and G.G. Collis and A.M. Newbury and K. Chan and C. Bower and P.D. Sly and Peter Lesouef",
    year = "1994",
    doi = "10.1183/09031936.94.07122185",
    language = "English",
    volume = "7",
    pages = "2185--2191",
    journal = "The European Respiratory Journal",
    issn = "0903-1936",
    publisher = "European Respiratory Soc Journals Ltd",

    }

    The influence of age on aerosol deposition in children with cystic fibrosis. / Chua, H.L.; Collis, G.G.; Newbury, A.M.; Chan, K.; Bower, C.; Sly, P.D.; Lesouef, Peter.

    In: European Respiratory Journal, Vol. 7, 1994, p. 2185-2191.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The influence of age on aerosol deposition in children with cystic fibrosis

    AU - Chua, H.L.

    AU - Collis, G.G.

    AU - Newbury, A.M.

    AU - Chan, K.

    AU - Bower, C.

    AU - Sly, P.D.

    AU - Lesouef, Peter

    PY - 1994

    Y1 - 1994

    N2 - Nebulized aerosols are commonly used to deliver drugs for the treatment of respiratory disease in children, but there are inadequate data on the dose of drug depositing in the lungs in this age group, and the effect of age on this dose, We therefore aimed to quantify total and regional deposition of nebulized aerosol in children of widely differing age.Twelve infants (median age 0.8 yrs, range 0.3-1.4 yrs) who were asleep, and eight older children (median age 10.8 yrs, range 6.3-18.0 yrs) with cystic fibrosis were studied. Radiolabelled normal saline aerosol was generated by a Turret nebulizer, with a driving flow of 9 l.min(-1). Ah subjects inhaled aerosol via the nasal route, whilst the older children undertook a second study with inhalation via the oral route, Following aerosol inhalation, planar and single-photon emission computed tomography (SPECT) scans were obtained.For the nasal route, total lung deposition was lower in infants (median 1.3%, range 0.3-1.6%) than in older children (median 2.7%, range 1.6-4.4%). For the older children inhaling via the nasal or oral route, there was no influence of age on lung, upper respiratory tract, or the sum of upper respiratory tract and lung deposition.We conclude that the dose of a nasally inspired aerosol reaching the lungs of infants who are asleep is approximately half that for older children, when the nebulizer is operating at 9 l.min(-1). Age does not affect deposition of nasally or orally inspired aerosols in older children.

    AB - Nebulized aerosols are commonly used to deliver drugs for the treatment of respiratory disease in children, but there are inadequate data on the dose of drug depositing in the lungs in this age group, and the effect of age on this dose, We therefore aimed to quantify total and regional deposition of nebulized aerosol in children of widely differing age.Twelve infants (median age 0.8 yrs, range 0.3-1.4 yrs) who were asleep, and eight older children (median age 10.8 yrs, range 6.3-18.0 yrs) with cystic fibrosis were studied. Radiolabelled normal saline aerosol was generated by a Turret nebulizer, with a driving flow of 9 l.min(-1). Ah subjects inhaled aerosol via the nasal route, whilst the older children undertook a second study with inhalation via the oral route, Following aerosol inhalation, planar and single-photon emission computed tomography (SPECT) scans were obtained.For the nasal route, total lung deposition was lower in infants (median 1.3%, range 0.3-1.6%) than in older children (median 2.7%, range 1.6-4.4%). For the older children inhaling via the nasal or oral route, there was no influence of age on lung, upper respiratory tract, or the sum of upper respiratory tract and lung deposition.We conclude that the dose of a nasally inspired aerosol reaching the lungs of infants who are asleep is approximately half that for older children, when the nebulizer is operating at 9 l.min(-1). Age does not affect deposition of nasally or orally inspired aerosols in older children.

    U2 - 10.1183/09031936.94.07122185

    DO - 10.1183/09031936.94.07122185

    M3 - Article

    VL - 7

    SP - 2185

    EP - 2191

    JO - The European Respiratory Journal

    JF - The European Respiratory Journal

    SN - 0903-1936

    ER -